Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma

Rationale: Mepolizumab, an IL-5–blocking antibody, reduces exacerbations in patients with severe eosinophilic asthma. Mepolizumab arrests eosinophil maturation; however, the functional phenotype of eosinophils that persist in the blood and airway after administration of IL-5 neutralizing antibodies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Kelly, Elizabeth A., Esnault, Stephane, Liu, Lin Ying, Evans, Michael D., Johansson, Mats W., Mathur, Sameer, Mosher, Deane F., Denlinger, Loren C., Jarjour, Nizar N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736971/
https://ncbi.nlm.nih.gov/pubmed/28862877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201611-2234OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados